B-cell lymphoma stage IV
(UMLS:C0855094)
- UMLS ID:
- C0855094
- MeSH ID:
- N/A
Synonym(s)
1.
B-cell lymphoma stage IV
2.
Ann Arbor Stage IV B-Cell Non-Hodgkin Lymphoma
3.
B Cell Lymphoma Stage IV
4.
B-Cell Lymphoma Stage IV
5.
Stage IV B Cell Lymphoma
6.
Stage IV B-Cell Lymphoma
7.
Stage IV B-Cell Non-Hodgkin Lymphoma
8.
Stage IV B-Cell Non-Hodgkin's Lymphoma
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Fingolimod Hydrochloride | FAERS: 1 | US FAERS | |
| 2 | Ranolazine | FAERS: 1 | US FAERS | |
| 3 | Teriparatide | FAERS: 1 | US FAERS | |
| 4 | carbidopa, levodopa drug combination | FAERS: 1 | US FAERS | |
| 5 | Etodolac | OFFSIDES | ||
| 6 | Hydrocortisone | OFFSIDES | ||
| 7 | Mitoxantrone | OFFSIDES | ||
| 8 | Prednisolone | OFFSIDES | ||
| 9 | Pyridoxal Phosphate | OFFSIDES | ||
| 10 | Ribavirin | OFFSIDES | ||
| 11 | Risedronic Acid | OFFSIDES | ||
| 12 | Sulfasalazine | OFFSIDES | ||
| 13 | alfacalcidol | OFFSIDES | ||
| 14 | fludarabine phosphate | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.